Hypertension

How routine eye checkups can reveal disease years before symptoms emerge

From heart health to neurological decline, the eye's tiny vessels and nerves can reveal silent disease changes long before patients notice anything is wrong

Childhood hypertension has doubled globally in 20 years, Lancet warns

A major meta-analysis shows hypertension has surged from just over 3% to more than 6% among people under 19, raising urgent concerns for parents, schools, and health systems

Hypertension cases among children, teens doubled in 2 decades: Study

Prevalence of hypertension or high blood pressure among children and teenagers has nearly doubled in the last two decades, from 3.2 per cent in 2000 to over six per cent in 2020, according to a global analysis published in The Lancet Child and Adolescent Health journal. Left unaddressed, hypertension can lead to cardiovascular and kidney disease. Estimates also suggest that nearly a fifth of the world's children and adolescents with obesity have hypertension -- about eight times the prevalence among those having a healthy weight (2.4 per cent), researchers including those from the UK's University of Edinburgh said. The findings suggest obesity is a substantial driver of the increase in childhood hypertension. Obesity tends to cause other issues, such as insulin resistance and changes in blood vessels, which can make it harder to maintain a healthy blood pressure. Further, eight per cent of children and teenagers around the world may be having pre-hypertension, which is a warning si

Soon, Pixel Watch may get Apple Watch-like hypertension alerts: Here's how

Google's Fitbit Labs is reportedly testing two new health features - one that studies early signs of hypertension and another that alerts users when their wellness metrics deviate from usual patterns

Pregnancy hypertension raises women's cardiovascular risk, finds study

These findings underscore the growing body of evidence over the past two decades linking pregnancy-related hypertension to long-term maternal health risks

US FDA clears Apple Watch feature rollout for hypertension detection

Apple said the new hypertension notification feature will be available on Apple Watch Series 9, Series 10, Series 11, and the premium Ultra 2 and Ultra 3 models before the end of September

Apple Watch's hypertension detection feature gets US FDA approval: Report

Apple secures FDA approval for its hypertension detection feature, reportedly set to roll out next week on eligible Apple Watch models, including Series 9, 10, 11, Ultra 2, and Ultra 3

New drug offers hope for Indians with drug-resistant hypertension

Baxdrostat lowered systolic blood pressure by 9-10 mmHg in trials and could benefit Indian patients with resistant hypertension by reducing side effects of older drugs

Why men are more likely to die from diabetes, hypertension and HIV

A global study in PLOS Medicine shows men have higher death rates from diabetes, hypertension and HIV/AIDS, largely due to risky lifestyles and lower healthcare use

New guidelines on blood pressure management: What you need to know

The American Heart Association now advises personalised care, home monitoring, and lifestyle-first strategies to curb the growing burden of hypertension

What rising blood pressure means for your health, and what to do about it

Hypertension affects over 220 million Indians but few get diagnosed or treated in time-here's how to understand and manage both high and low BP

Delhi schoolkids face surge in obesity and hypertension, warns Aiims study

A new Aiims study reveals a worrying rise in obesity, hypertension and hidden metabolic risks among Delhi schoolchildren, especially those in private schools

Alembic Pharma receives USFDA approval for generic hypertension drug

Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for its generic version of amlodipine and atorvastatin tablets, used to treat high blood pressure. The final approval by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Amlodipine and Atorvastatin tablets of strengths 2.5 mg/10 mg, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, the company said in a statement. These are therapeutically equivalent to the reference-listed drug product, Caduet tablets of corresponding strengths of Pharmacia and Upjohn Co LLC, it added. Alembic said it has a cumulative total of 223 ANDA approvals (199 final approvals and 24 tentative approvals) from the USFDA.

Do not apply for health cover without revealing existing hypertension

Try bringing condition under control to improve chances of getting coverage

Study finds men more likely to fall sick, die from 3 common health issues

Men in many countries are more likely to fall sick and die from hypertension, diabetes, and HIV/AIDS as compared to women, according to a new study. However, compared to women, men were found to be less likely to seek medical care and adhere to treatment for these common health conditions due to norms related to masculinity and healthcare financing. Men were also more likely to smoke, while women were more likely to be obese and engage in unsafe sex, the study, published in the journal PLOS Medicine, found. The research highlights sex-based differences at each step of the "health pathway", which includes being exposed to a risk factor -- such as smoking -- developing a condition, diagnosis, treatment and death, study authors said. "Most of these differences are not explained by sex (biology) alone, but by socially-constructed gender -- highlighting the importance of taking a gender justice approach to reducing health inequities. A gender analysis can help to shape systems of health

Alembic Pharmaceuticals gets USFDA nod for hypertension treatment capsules

Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic Diltiazem Hydrochloride extended-release capsules indicated for the treatment of hypertension. The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for Diltiazem Hydrochloride Extended-Release Capsules of strengths 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg, Alembic Pharmaceuticals Ltd (Alembic) said in a statement. These capsules are indicated for the treatment of hypertension. These capsules may be used alone or in combination with other antihypertensive medications. Moreover, Diltiazem Hydrochloride is also indicated for the management of chronic stable angina and angina due to coronary artery spasm, the company said. Diltiazem Hydrochloride extended-release capsules 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg have an estimated market size of USD 105.3 million for the 12 months ended June 2024, the company ...

World Hypertension Day 2024: History, significance, theme, date and more

World Hypertension Day 2024: This day is celebrated every year to raise awareness about the risk of hypertension and its preventive measures. Here's all you need to know about this day

Omron's India arm, AliveCor to market AI-based portable ECG in India

While stroke risk is 3.4 times higher with hypertension, it becomes nearly five times higher with Afib, which means that people who frequently experience Afib could face a stroke shortly

Prefer deductible to co-pay in senior citizen health insurance cover

Last week Tata AIG General Insurance launched a plan for this group, adding to the considerable number of plans already available

Over 11.4% Indians diabetic, 35.5% suffer from hypertension: Lancet journal

The prevalence of diabetes in India is 11.4 per cent, while 35.5 per cent of people suffer from hypertension, according to the findings of a nationwide survey published in The Lancet Diabetes & Endocrinology journal. The study, conducted by the Madras Diabetes Research Foundation in collaboration with the Indian Council of Medical Research (ICMR) and other institutes, also found that the prevalence of generalised obesity and abdominal obesity in India stood at 28.6 and 39.5 per cent, respectively. The results, assessing the burden of non-communicable diseases (NCD) across the states, are based on a survey of 1,13,043 (over 1.1akh) people (33,537 urban and 79,506 rural residents), in 31 states and Union Territories in the country, between 2008 and 2020. The survey also showed that 35.5 per cent of Indians suffer from hypertension, 15.3 per cent of people have pre-diabetes, while an alarming 81.2 per cent have dyslipidaemia -- the imbalance of lipids such as cholesterol, low-density